Philip Ward and Rebekah Moan[email protected]BreastControversy persists over breast screening for under 50sVIENNA - Screening is effective in reducing breast cancer mortality in women ages 40 to 49, but false positives remain a serious problem, European Congress of Radiology attendees were told at a special focus session on Friday.March 2, 2012Page 1 of 1Top StoriesMRIFDA cites MRI study in new requirements for COVID-19 manufacturersCardiac MRI exams played a part in the U.S. FDA's requirements recently issued on COVID-19 vaccines and heart inflammation.Molecular ImagingSNMMI: Consider radiation safety when adding F-18 MPI to the radiation oncology suiteCTACS: Half of cancer mortality due to modifiable risk factorsRisk ManagementSNMMI: For PET drugs, sterility assurance bests sterility testingSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
